FDA commissioner search: Pittsburgh's Juhl could be politically appealing candidate.
This article was originally published in The Rose Sheet
Executive Summary
FDA COMMISSIONER SEARCH: PITTSBURGH PHARMACY PROFESSOR JUHL, one of the first names being widely discussed as a successor to Commissioner David Kessler could offer an appealing package of attributes considering the political environment surrounding the selection process. University of Pittsburgh School of Pharmacy Dean Randy Juhl, PhD, the inaugural chairman of FDA's Nonprescription Drugs Advisory Committee, could be presented as an advocate of consumer access to technologies and a progressive role for FDA within the total economy. He was a key participant in the agency's stepped up efforts to expand consumer access to medicines via the Rx-to-OTC switch process.